>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: VCEL +18.6%, STMP +17.7%, HIIQ +12.7%, SODA +12.3%, AEZS +12.1%, CROX +9.2%, CECE +7%, NVRO +6.4%, AKRX +5.6%, WWAV +5.4%, FGEN +4.6%, STXS +4.6%, OPK +4.4%, MHGC +4.3%, DTSI +4.2%, PFNX +4%, HTZ +3.9%, ARNA +3.2%, DPLO +3.1%, HALO +2.9%, XIN +2.9%, GRBK +2.6%, IFF +2.6%, ING +2.6%, OAS +2.5%, KITE +2.1%, MXL +2.1%, GTXI +2%, TREX +2%, TTNP +2%, AGN +2%, TDG +1.9%, TUBE +0.9%, PAH +0.8%

M&A news: ALXA +72.2% (to be acquired by Ferrer Pharma for $0.90 per share), TEX +2.8% (speculation Zoomlion (ZLIOY) could be near completing financing for its previously announced bid to acquire Terex)

Select Chinese ADRs showing strength after late day weakness yesterday: VNET +7.2%, MOMO +5%, AMCN +3.9%, YY +3.5%, QIHU +3.1%

Select metals/mining stocks trading higher: CLF +4%, MTL +3.9%, VALE +3%, FCX +2.4%, EGO +2.1%

Other news: CCXI +111.9% (announces Vifor Pharma has licensed rights to commercialize CCX168), AKRX +7.8% (files form 10-K (previously delayed)), CYTX +3.8% (announces the EC has granted orphan drug status to a broad range of Cytori Cell Therapy formulations), DB +2.7% (in sympathy with CS and ING (both reported earnings, trading higher in EU mkts)), BCS +2.3% (in sympathy with CS and ING (both reported earnings)), AMZN +2.1% ( Acacia Research (ACTG), entered into a settlement and license agreement with Amazon (AMZN)), SNY +1.4% (still checking), HSBC +0.5% (in sympathy with CS and ING (both reported earnings))

Analyst comments: GNC +1% (initiated with a Overweight at Piper Jaffray)

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: SCTY -19.3%, MNKD -18.2%, BIOL -13.7%, GPS -11.7%, BLOX -11.4%, FRGI -10.9%, VSLR -9.7%, SEDG -9%, LL -8.9%, SSNI -8.4%, GEN -7.9%, NVCR -7.9%, ZBRA -7.3%, VVC -6.7%, CFRX -6.4%, AAOI -6.3%, NCLH -6.2%, BDSI -6%, RBC -6%, BIOD -5.8%, INVN -5.5%, AMID -5.4%, GNK -5.2%, INGN -5.1%, ARLZ -5%, PLUG -4.7%, EZPW -3.8%, LSCC -3.7%, GLOB -3.5%, ACM -3.4%, NOK -3.3%, CVU -3%, NOK -2.8%, CS -2.8%, ARIA -2.8%, BKD -1.7%, RAX -1.5%, HK -1.4%, BSM -1.2%, EVEP -0.8%, FSC -0.8%, KNDI -0.7%

Other news: NLNK -34.8% (results of its Phase 3 clinical trial for algenpantucel-L for patients with resected pancreatic cancer did not achieve primary endpoint, also reported earnings), TSE -5.7% (Bain Capital Everest Manager to sell 8 mln ordinary shares pursuant to shelf registration), LC -2.8% (The SEC will review LendingClub's disclosures following today's announced irregularities, according to Bloomberg), ZTS -2.1% (Bill Ackman's Pershing Square is selling nearly 17 mln shares of Zoetis, according to the NYTimes), VRX -1.9% (continued volatility in pre-mkt trade), ED -1.7% (to commence registered underwritten public offering of 8.8 mln common shares)

Analyst comments: SFM -2.7% (downgraded to Sell from Neutral at Goldman), CHKP -1% (downgraded to Neutral from Buy at Citigroup), JD -0.9% (downgraded to Neutral from Outperform at Credit Suisse), AFL -0.8% (downgraded to Mkt Perform from Outperform at FBR Capital)

>>> Zoomlion nears completion of Terex financing; could table formal bid in a co

Zoomlion nears completion of Terex financing; could table formal bid in a couple of weeks

* Aims for Terex to overturn Konecranes recommendation
* Funding to comprise cash on hand plus on- and offshore debt
* SAFE approval needed

Zoomlion Heavy Industry [SHE: 000157, HKG: 1157] is close to completing the necessary financing to be in a position to turn its preliminary rival USD 31 per share cash offer for US-based Terex [NYSE: TEX] into a binding one, two sources close to the process said.

The China-based heavy equipment manufacturer has received commitments for more money than needed to cover its competing offer for Terex and is now in the process of deciding how to divvy up its borrowings, one of the sources said. It should be able to approach the Terex board in a couple of weeks with the aim of having it agree to and recommend Zoomlion’s higher offer, this first source said.

The Terex board is currently recommending an all-share offer from Finnish crane manufacturer Konecranes [HEL: KCR1V], which as of May 9 had an implied value of USD 18.26 per share. But the US company is also in talks with Zoomlion to determine if it can obtain a fully financed proposal with a high degree of closing certainty. Talks are focused on Zoomlion’s certainty of financing, shareholder approval, governmental approvals and the details of a reverse break-up fee.

According to the first source, Zoomlion will use about USD 1.5bn of cash from its balance sheet and borrow the remainder. Its preliminary offer has an implied enterprise value of about USD 4.87bn, based on 108.5m outstanding shares and including USD 1.51bn of net debt as of 31 March 2016, Dealreporter analytics show.

The second source said the deal will be financed with approximately one-third cash, two-thirds bank lending and added that Zoomlion is close to finalising an agreement with China Development Bank for a CNY 20bn (USD 3.08bn) CDB-led loan that will come with a 1%-2% government interest rate subsidy.

The Changsha-based company is planning to raise another CNY 10bn from overseas sources to reduce the risks associated with State Administration of Foreign Exchange (SAFE) approvals for transferring money out of China, the same source said. Not all of that money will be used towards the Terex acquisition, though. Some of it will be set aside for other deals that are currently in the works, or that may be explored in the future, the second source said.

Chinese outbound deals exposed to SAFE are being watched closely by advisors and investors amid concern the regulator has slowed down its approval process since February, as reported.

Wants to maximise offshore borrowing

Other Chinese banks are expected to participate in the CDB-led loan and part of the money will be provided by overseas branches of these banks. According to the second source, Zoomlion was previously in talks with Bank of China’s Milan branch although talks ended.

The first source declined to provide a breakdown, but noted that Zoomlion wants to maximise its offshore borrowing to make Terex’s board comfortable that a potential deal won’t be tripped up by SAFE.

These risks won’t be eliminated altogether though, as Zoomlion will borrow some money onshore and will also need SAFE approval to exchange its balance sheet cash into US dollars, this source added.

In the event Terex changes its recommendation, Konecranes may terminate the agreement and receive a fee equal to USD 37m, as previously reported.

A source familiar with the situation told this news service in April that Konecranes is “fully prepared” for discussions about alternatives if Terex deems Zoomlion's latest offer superior. But Konecranes’ board will not destroy value for its own shareholders just to outdo Zoomlion, the source familiar cautioned.

Terex has faced deteriorating quarterly sales and earnings since Konecranes’ offer in August 2015 and as the two companies’ share prices have fallen, the implied value of the all-stock merger, which will give Terex shareholders 0.8 share in Konecranes for each of their Terex shares, has come down. On top of that, US tax reforms flagged on 27 April, would erase some EUR 32m (USD 36.5m) in post-income benefits from the Terex/Konecranes tie-up, as reported.

Zoomlion, on 27 January, announced it had made a non-binding USD 30 per share cash proposal for Terex and in mid-February said it had a concrete financing plan comprising a 40:60 mix of cash on hand and bank loans. It also noted that it had received letters of support from relevant banks.

On 24 March, the Chinese company increased its non-binding offer price to USD 31 per share. It has made no further public announcements about the financing structure since then.

1Q earnings drop

Zoomlion had USD 1.77bn of cash and cash equivalents at the end of 2015. By the end of 1Q16 this had decreased slightly to CNY 10.5bn (USD 1.61bn), according to its latest results announcement.

The company’s 1Q16 results were worse than analysts had expected, with a 20% decrease in operating income year-on-year and several other key measures also down.

A person in Zoomlion’s investor relations department said the company has abundant credit lines with lenders both in China and abroad. According to its 2015 annual report, unused credit facilities stood at more than CNY 79.5bn at the end of last year.

Equity funding is not considered an option since Zoomlion is trading below book value.

At the end of 1Q16, the company had net debt of CNY 14.7bn (CNY 1.1bn of that matured on 20 April), which together with a 12-month rolling EBITDA of CNY 2.1bn put its operating net leverage at 6.7x EBITDA.

If Zoomlion were to take on an additional CNY 30bn of debt, the net leverage would rise to 7.5x on a pro-forma basis (when Terex financials are consolidated with Zoomlion after acquisition), Dealreporter analytics show.

Terex shares closed at USD 23.41 on Monday, representing a 28.2% premium over Konecranes’ implied offer price and a 24.5% discount to Zoomlion’s preliminary offer.

Terex declined to comment

>>> US Early premarket gappers


Early premarket gappers

Gapping up: CCXI +114.3%, ALXA +75.9%, HIIQ +21.6%, STMP +17.8%, AEZS +12.1%, ACM +6.9%, HALO +6.6%, NVRO +6.4%, MXL +4.7%, FGEN +4.6%, STXS +4.6%, AGN +4.3%, VALE +4.2%, DTSI +4.2%, CLF +4%, PFNX +4%, MTL +3.9%, MHGC +3.8%, OPK +3.8%, QIHU +3.6%, MOMO +3.5%, AKRX +3.4%, YY +3.3%, BCS +3.2%, ARNA +3.2%, DPLO +3.1%, NRF +3.1%, SDRL +2.7%, GRBK +2.6%, IFF +2.6%, DB +2.5%, NLS +2.3%, CHK +2.2%, HTZ +2.2%, KITE +2.1%, AMZN +1.8%, WLL +1.5%, SNY +1.4%, HSBC +1.2%, LC +1.1%, TUBE +0.9%, PAH +0.8%, NCLH +0.5%, RARE +0.5%

Gapping down: NLNK -34%, SCTY -18.7%, MNKD -17.4%, BIOL -13.7%, GPS -13.4%, BLOX -13%, AAOI -10%, VSLR -9.7%, FRGI -9.5%, LL -8.9%, SSNI -8.9%, SEDG -8.4%, SYNC -7.9%, GEN -7.9%, INVN -7.8%, NVCR -7.1%, PLUG -6.7%, VVC -6.7%, RBC -6%, BIOD -5.8%, AMID -5.4%, TSE -5.3%, INGN -5.1%, EZPW -3.8%, LSCC -3.7%, GLOB -3.5%, NOK -3.3%, ZTS -3.2%, ED -2%, AU -2%, RAX -1.5%, VRX -1.4%, HK -1.4%, BSM -1.2%, GWPH -1%, ZBRA -0.9%, AFL -0.8%, EVEP -0.8%, FSC -0.8%, GTXI -0.8%, KNDI -0.7%

(Handelsblatt) How aggressive investors are using dubious analyst reports to inf

How aggressive investors are using dubious analyst reports to influence stock prices – and how companies fight back

For senior managers at Stada, a publicly-listed German pharmaceutical company, the week began with loud alarm bells ringing.

The investor Active Ownership Capital had bought a large stake in the company and wasted no time in going on the attack: five of the 6 members of the board had to go, demanded the new investors.

To support their claim, they published a report written by the investment group’s own analysts, claiming to show that Stada’s share price and its business were falling far behind its rivals.

This is just one example among many of an attack made with the help of analysts.

Almost every week, activist investors show up at some company or other, with a devastating report in hand, propagating dubious information and demanding radical changes. The short-term goal is usually to move the share price one way or another.

And it usually works.

The weapon of choice here is the in-house analyst and their supposed well-researched, critical reports.

But unlike analysts at banks and investment houses, who are at least theoretically independent, these analysts produce knowledge to achieve a specific goal. No matter whether the aim is to drive a target share up or down, it usually causes a crisis in the company under attack.

The more executive bonuses are tied up with the stock price, the more sensitive investor relations managers get.

AN UNNAMED
HEAD OF STOCK MARKET RESEARCH AT A LARGE GERMAN BANK
Take outdoor advertising group Ströer: In April, a hedge fund, Muddy Waters, produced an analysis calling the advertiser’s balance sheet into question. Its stock fell 30 percent, and still has not recovered. Online payments company Wirecard suffered a similar attack earlier this year: Its share price crashed after short-sellers used analysts’ reports to cast doubt on the company’s health.

It isn’t easy for companies to defend themselves against the attacks. They are only illegal if information is deliberately falsified, or there is a purposefully concealed conflict of interest. In that case, they can be punished by a one to 5-year prison sentence for market manipulation.

On Monday, the German financial regulator Bafin issued a warning to investors about analysts’ reports.

But the warning mostly amounts to “buyer beware,” or “reader beware”: Investors should bear in mind that analysts can have their own ax to grind, and come to their own conclusions, said the report.

But the pressures are not all in one direction.

Relations between companies and analysts can be very tricky these days. This is not just because of analysts who churn out critical reports in the service of activist investors. There has been tension too between traditional bank analysts and over-stretched, over-sensitive investor relations managers.

Insiders will only speak about the battle over analysts’ ratings and recommendations on condition of anonymity. The head of stock market research at a large German bank said this of managers’ sensitivity: “The more executive bonuses are tied to the stock price, the more sensitive investor relations managers get.” And when corporate crises hit, that sensitivity goes through the roof.

Company pressure on analysts has a clear consequence: The vast majority of all analyst reports on German shares recommend a BUY. There is “pressure from companies on analysts,” said Ralf Frank, managing director of the German association of financial analysts, or DVFA. Even a “HOLD” recommendation can be seen as a negative judgment, which in turn can lead to companies giving analysts seen as hostile the cold shoulder.

But some company reactions are understandable.

Analysts do regularly make a huge difference. When Goldman Sachs changed its rating on BMW to “BUY” in mid-April, the share price shot up. According to research by Pierre Drach, the owner of Independent Research, an analysis firm, companies in comparatively good shape tend to react worst to poor ratings – they are unaccustomed to tough questions and negative judgments.

And there are plenty of nervous investor relations managers out there. Volkswagen’s emissions scandal and product recalls have made many car makers twitchy about analyst ratings. So is clothing maker Boss, now faced with heavy restructuring. “Everyone’s nerves are on absolutely edge at Boss,” an analyst at a German investment firm told Handelsblatt.

Some firms are hitting back. Norbert Steiner, the chairman of the salt maker K+S, thinks analysts failed to acknowledge the strength of their potash mining operations in Canada. “I am extremely unhappy that most analysts simply failed to include that value in their long-term evaluations,” he said.

Companies sometimes respond indirectly, freezing out analysts they see as hostile, who can suddenly find investor relations managers harder to contact.

Unpopular analysts are sometimes excluded from conference calls or results presentations.

If they are invited, they may find themselves on the receiving end of a tirade. “The CEO was so enraged by one study that he invited me over. Within a couple of minutes, he had shouted the ‘F-word’ at me 6 times,” said a British analyst generally seen as critical. “But I wear it like a badge of honor. It means you’ve hit a nerve,” he added.

Cunning methods may get better results. “Sandbagging” is a well-known practice, particularly in the United States. This involves companies deliberately downplaying forthcoming results to analysts, only then to “beat market expectations” when things turn out better than predicted.

Shouldn’t analysts spot the trick?

“Most of the time analysts just believe what companies tell them,” said one critic, Atul Lele, the chief investment officer at Deltec International, a logistics company for the financial industry. “A company talks down expectations, and the analyst goes ahead and plugs their numbers into his model.”

The CEO was so enraged by one study that he invited me over. Within a couple of minutes, he shouted the ‘F-word’ at me 6 times.

PROMINENT BRITISH STOCK MARKET ANALYST
So it is hardly surprising when some analysts get cynical. No one wants to speak publicly about it, but studies show that analysts rate companies considerably better if they are about to issue new shares or bonds, bringing new business to the analysts’ banks.

In some cases, analysts have been highly selective in releasing information: In 2014, the U.S. Financial Industry Regulatory Authority hit Citigroup with a $15 million fine. Citi analysts had invited selected customers to a dinner, then given them their real assessments of shares, which was quite different from their public ratings.

The bottom line: Critical analyses are legal, as long as any possible conflict of interest is made public. Even short selling is OK, as long as these guidelines are followed, says the German regulator, Bafin.

But investor advocates say this is not good enough. Jürgen Kurz, the spokesman for DSW, Germany’s oldest and largest association for private investors, argues that banks should be made liable for their analysts’ public judgments.

“It would make sense if legislators would establish norms of liability in this area,” he said.

>>> Data Could Be an Antitrust Issue If Scarce, Regulators Say

Ownership of data might be an antitrust issue if that information isn’t available to others, the German and French antitrust authorities say in a joint report
  • Regulators have so far mostly looked at data in merger cases like Facebook/WhatsApp and Google/Doubleclick
  • “Data advantage” that gives firms power over rivals hasn’t yet been examined as a possible monopoly abuse
  • Data gathered by networks “may be as rich or even richer” than search engines
Full Doc attached

FT : Brazil impeachment proceedings back on track against Dilma Rousseff

Brazil impeachment proceedings back on track against Dilma Rousseff

A vote to impeach Brazil’s Dilma Rousseff is back on track after the acting head of the lower house reversed an earlier decision to suspend the action against the president who is accused of illegally using state funds to plug a hole in the budget.
The speaker, Waldir Maranhão, released a statement overnight revoking his earlier call to annul impeachment proceedings in the lower house.

Attention will now turn to the Senate, the country’s upper house, which is set to vote on Wednesday on whether to put the president on trial. If successful, the action would temporarily remove her from office.
Investor concern that lawmakers were stalling on their decision to impeach the president had earlier sparked a sell-off in Brazilian assets on Monday, with the real and the benchmark Ibovespa stock index both falling.
But after Mr Maranhão’s about turn, Senate President Renan Calheiros said he would move ahead with impeachment proceedings, accusing his counterpart in the lower house of “toying with democracy”.
Opposition legislators cheered his decision while supporters of the government stood up and shouted at the senator in protest.
The upper chamber needs support from two-thirds of its 81 members to permanently remove the president from office. If the Senate now votes for impeachment, Michel Temer, who as vice-president has assumed her duties, is expected to enter immediate talks to form a new cabinet including the appointment of the former central bank governor, Henrique Meirelles, as his heavyweight finance minister.
Ms Rousseff’s allies had spent most of Monday trying to capitalise on the confusion sown by the lower house leader’s call to annul last month’s impeachment vote.
Jose Eduardo Cardozo, the attorney-general, said the administration could file an appeal with the Supreme Court by arguing that Maranhao was right in trying to halt the process.
Brazil’s new president will have a chance to steady the ship
Brazil's vice President Michel Temer talks with the press in Brasilia, on April 11, 2016. Temer -- who would take over if Dilma Rousseff is impeached -- on Monday accidentally released the speech he'd give to the nation if she were forced to stand aside, reports said. / AFP PHOTO / ANDRESSA ANHOLETEANDRESSA ANHOLETE/AFP/Getty Images
Michel Temer’s first task is to win over investor confidence and stabilise the economy
Earlier, Mr Maranhão argued that lower house deputies should not have announced their intention ahead of the April 17 vote to send the motion on to the Senate.
However overnight, in a surprise move, Mr Maranhão reversed his earlier call.
“I revoke my decision issued May 9, 2016, in which the lower house sessions were annulled,” Mr Maranhão was cited as saying in a statement released by his office. No further reason was given.
Some questioned the motives of Mr Maranhão, a little-known politician from the country’s north-east who himself is under investigation for corruption. The president seemed taken aback by his announcement and urged caution during a speech earlier in the day.